Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Matsumura

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2026
Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based studyYoshinori Takahashi, Kazuki Matsui, Naoya Matsumura, et al.
Pharmaceutics|September 9, 2020
Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base DrugsNaoya Matsumura, Asami Ono, Yoshiyuki Akiyama, et al.
Journal of Pharmaceutical Sciences|June 4, 2018
Evaluation of Using Dogs to Predict Fraction of Oral Dose Absorbed in Humans for Poorly Water-Soluble DrugsNaoya Matsumura, Yoshiyuki Yamaura, Jun Katagi, et al.
European Journal of Pharmacology|February 24, 2015
Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigsYasuo Yonetomi, Tomohiko Sekioka, Michiaki Kadode, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 16, 2017
A new CysLT<sub>1</sub> and CysLT<sub>2</sub> receptors-mediated anaphylaxis guinea pig modelTomohiko Sekioka, Michiaki Kadode, Noriko Osakada, et al.
Journal of Pharmaceutical Sciences|March 26, 2019
Prediction Accuracy of Mechanism-Based Oral Absorption Model for DogsYoshiyuki Akiyama, Takahiro Kimoto, Hanae Mukumoto, et al.
Drug Metabolism and Pharmacokinetics|February 5, 2014
Development of mice exhibiting hepatic microsomal activity of human CYP3A4 comparable to that in human liver microsomes by intravenous administration of an adenovirus vector expressing human CYP3A4Shuichi Kuno, Fuminori Sakurai, Kahori Shimizu, et al.
Bioorganic & Medicinal Chemistry|September 21, 2011
Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF₁) receptor antagonistsTetsuji Saito, Tetsuo Obitsu, Chiaki Minamoto, et al.
Bioorganic & Medicinal Chemistry|March 25, 2015
Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acidSatoshi Itadani, Shinya Takahashi, Masaki Ima, et al.
Bioorganic & Medicinal Chemistry|August 26, 2011
6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonistsTetsuji Saito, Tetsuo Obitsu, Takashi Kondo, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2026
Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based studyYoshinori Takahashi, Kazuki Matsui, Naoya Matsumura, et al.
Pharmaceutics|September 9, 2020
Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base DrugsNaoya Matsumura, Asami Ono, Yoshiyuki Akiyama, et al.
Journal of Pharmaceutical Sciences|June 4, 2018
Evaluation of Using Dogs to Predict Fraction of Oral Dose Absorbed in Humans for Poorly Water-Soluble DrugsNaoya Matsumura, Yoshiyuki Yamaura, Jun Katagi, et al.
European Journal of Pharmacology|February 24, 2015
Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigsYasuo Yonetomi, Tomohiko Sekioka, Michiaki Kadode, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 16, 2017
A new CysLT<sub>1</sub> and CysLT<sub>2</sub> receptors-mediated anaphylaxis guinea pig modelTomohiko Sekioka, Michiaki Kadode, Noriko Osakada, et al.
Journal of Pharmaceutical Sciences|March 26, 2019
Prediction Accuracy of Mechanism-Based Oral Absorption Model for DogsYoshiyuki Akiyama, Takahiro Kimoto, Hanae Mukumoto, et al.
Drug Metabolism and Pharmacokinetics|February 5, 2014
Development of mice exhibiting hepatic microsomal activity of human CYP3A4 comparable to that in human liver microsomes by intravenous administration of an adenovirus vector expressing human CYP3A4Shuichi Kuno, Fuminori Sakurai, Kahori Shimizu, et al.
Bioorganic & Medicinal Chemistry|September 21, 2011
Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF₁) receptor antagonistsTetsuji Saito, Tetsuo Obitsu, Chiaki Minamoto, et al.
Bioorganic & Medicinal Chemistry|March 25, 2015
Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acidSatoshi Itadani, Shinya Takahashi, Masaki Ima, et al.
Bioorganic & Medicinal Chemistry|August 26, 2011
6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonistsTetsuji Saito, Tetsuo Obitsu, Takashi Kondo, et al.
Pageof 2